Prashant Yadav
@prof-yadav.bsky.social
Better health & economic development through better supply chains, globally. #globalhealth #supplychain #pharmaceuticals #vaccine #access
With 43 million deaths/ y (73% in LMICs) due to #NCDs, we need operational implementation, not just declarations. Pragmatic delivery systems to supply medicines, and smarter demand forecasting are 2 simple ones to start with. My short article after the UNGA-HLM on NCDs. jointly with Aly Martinez.
October 20, 2025 at 11:53 AM
With 43 million deaths/ y (73% in LMICs) due to #NCDs, we need operational implementation, not just declarations. Pragmatic delivery systems to supply medicines, and smarter demand forecasting are 2 simple ones to start with. My short article after the UNGA-HLM on NCDs. jointly with Aly Martinez.
Since 2020, I have frequently joined Tommy Tucker and WWL Radio's morning show to discuss pharmaceutical supply issues for their listeners in New Orleans and across the Gulf Coast. This morning, we talked about the Trump Administration’s pharmaceutical tariffs
@cfr.org
audacy.com/podcast/wwl-...
@cfr.org
audacy.com/podcast/wwl-...
August 8, 2025 at 1:39 PM
Since 2020, I have frequently joined Tommy Tucker and WWL Radio's morning show to discuss pharmaceutical supply issues for their listeners in New Orleans and across the Gulf Coast. This morning, we talked about the Trump Administration’s pharmaceutical tariffs
@cfr.org
audacy.com/podcast/wwl-...
@cfr.org
audacy.com/podcast/wwl-...
Procuring #pandemic #countermeasures needs new skills, smarter contracts & higher risk tolerance. Demand is highly volatile, suppliers may be new, production incentives are weak, & often need #procurement before reg approval. Key themes I shared at the recent ADB symposium on pandemics.
@cfr.org
@cfr.org
July 13, 2025 at 10:54 AM
Procuring #pandemic #countermeasures needs new skills, smarter contracts & higher risk tolerance. Demand is highly volatile, suppliers may be new, production incentives are weak, & often need #procurement before reg approval. Key themes I shared at the recent ADB symposium on pandemics.
@cfr.org
@cfr.org
On 11 July 2025, the Asian Development Bank will host a Symposium on Multilateral Financing for Pandemic Preparedness and Response in Manila. The symposium features a session on procurement for medical countermeasures. You can also join us via Zoom: lnkd.in/ei7zKtX6.
July 8, 2025 at 7:49 PM
On 11 July 2025, the Asian Development Bank will host a Symposium on Multilateral Financing for Pandemic Preparedness and Response in Manila. The symposium features a session on procurement for medical countermeasures. You can also join us via Zoom: lnkd.in/ei7zKtX6.
The US needs to address the lack of supply resilience for critical generic medicines. But it needs other tools of industrial policy (hint: not tariffs). @jaredshopkins.bsky.social @wsj.com
www.wsj.com/health/pharm...
Thanks for including my thoughts.
#generic #pharma #supplychain #resilience
www.wsj.com/health/pharm...
Thanks for including my thoughts.
#generic #pharma #supplychain #resilience
June 22, 2025 at 9:43 AM
The US needs to address the lack of supply resilience for critical generic medicines. But it needs other tools of industrial policy (hint: not tariffs). @jaredshopkins.bsky.social @wsj.com
www.wsj.com/health/pharm...
Thanks for including my thoughts.
#generic #pharma #supplychain #resilience
www.wsj.com/health/pharm...
Thanks for including my thoughts.
#generic #pharma #supplychain #resilience
Amid #WHA78, the WHS session on “Taking Responsibility for Health in a Fragmented World” sparked some key reflections for me. Grateful to @Ilona Kickbusch for thoughtful questions on trade, industrial policy, & global health. Hope it sparks a continued dialogue. 👇images copyright World Health Summit
May 27, 2025 at 9:16 PM
Amid #WHA78, the WHS session on “Taking Responsibility for Health in a Fragmented World” sparked some key reflections for me. Grateful to @Ilona Kickbusch for thoughtful questions on trade, industrial policy, & global health. Hope it sparks a continued dialogue. 👇images copyright World Health Summit
If you are in Geneva at #WHA78 join us for this
@worldhealthsummit.bsky.social #WHS side event "Taking Responsibility for Health in a Fragmenting World."
📍 InterContinental Hotel - Ballroom A
🗓️ May 21, 2025 | 17:00 CEST
👉 Full program here: lnkd.in/dUbBEV8W
@cfr.org
@worldhealthsummit.bsky.social #WHS side event "Taking Responsibility for Health in a Fragmenting World."
📍 InterContinental Hotel - Ballroom A
🗓️ May 21, 2025 | 17:00 CEST
👉 Full program here: lnkd.in/dUbBEV8W
@cfr.org
May 20, 2025 at 5:00 PM
If you are in Geneva at #WHA78 join us for this
@worldhealthsummit.bsky.social #WHS side event "Taking Responsibility for Health in a Fragmenting World."
📍 InterContinental Hotel - Ballroom A
🗓️ May 21, 2025 | 17:00 CEST
👉 Full program here: lnkd.in/dUbBEV8W
@cfr.org
@worldhealthsummit.bsky.social #WHS side event "Taking Responsibility for Health in a Fragmenting World."
📍 InterContinental Hotel - Ballroom A
🗓️ May 21, 2025 | 17:00 CEST
👉 Full program here: lnkd.in/dUbBEV8W
@cfr.org
The new US Exec Order on pharma MFN pricing sticks to high-income countries (thankfully). But it risks reigniting broader MFN demands by MICs, jeopardizing low-tier prices critical for access in low-income countries. I unpack this in my latest ThinkGlobalHealth @cfr.org piece. (Link in next post) 👇
May 16, 2025 at 2:37 PM
The new US Exec Order on pharma MFN pricing sticks to high-income countries (thankfully). But it risks reigniting broader MFN demands by MICs, jeopardizing low-tier prices critical for access in low-income countries. I unpack this in my latest ThinkGlobalHealth @cfr.org piece. (Link in next post) 👇
In 👇 we argue that each country would pay a price pharmaceuticals that is commensurate with the value it provides to that country's health system.
pubmed.ncbi.nlm.nih.gov/32185365/
pubmed.ncbi.nlm.nih.gov/32185365/
May 12, 2025 at 2:10 AM
In 👇 we argue that each country would pay a price pharmaceuticals that is commensurate with the value it provides to that country's health system.
pubmed.ncbi.nlm.nih.gov/32185365/
pubmed.ncbi.nlm.nih.gov/32185365/
Creating a single price for pharmaceuticals (through MFN) is both inefficient and inequitable. There is sufficient and strong evidence for this. Also, an MFN clause hurts the poorest countries the most.
Links to my review studies and past work on this are in the following posts.
Links to my review studies and past work on this are in the following posts.
May 12, 2025 at 2:10 AM
Creating a single price for pharmaceuticals (through MFN) is both inefficient and inequitable. There is sufficient and strong evidence for this. Also, an MFN clause hurts the poorest countries the most.
Links to my review studies and past work on this are in the following posts.
Links to my review studies and past work on this are in the following posts.
The i3 program for African health startups is back for Phase 2! After backing 60 early-stage startups in Phase 1, we’re now supporting 7 growth-stage companies using innovative tech to improve pharmacy access for patients. 7 outstanding companies and founders ... #Africa #healthtech #i3 #pharmacy
May 1, 2025 at 12:31 AM
The i3 program for African health startups is back for Phase 2! After backing 60 early-stage startups in Phase 1, we’re now supporting 7 growth-stage companies using innovative tech to improve pharmacy access for patients. 7 outstanding companies and founders ... #Africa #healthtech #i3 #pharmacy
Rwanda is emerging as a leading example of building world-class digitalization+ tech into the health system. Driven by strong govt commitment & health sector leadership; national ID & insurance systems; expanded broadband access at clinics; and the support of nimble, responsive, and trusted partners
April 27, 2025 at 6:58 PM
Rwanda is emerging as a leading example of building world-class digitalization+ tech into the health system. Driven by strong govt commitment & health sector leadership; national ID & insurance systems; expanded broadband access at clinics; and the support of nimble, responsive, and trusted partners
Since 2020, I’ve been grateful to WWL Radio (which covers across New Orleans and the Gulf Coast) for having me on their morning show to discuss pharmaceutical supply issues. ~Last week, we covered questions around potential #pharmaceutical #tariffs.
audacy.com/podcast/wwl-...
audacy.com/podcast/wwl-...
April 25, 2025 at 6:42 PM
Since 2020, I’ve been grateful to WWL Radio (which covers across New Orleans and the Gulf Coast) for having me on their morning show to discuss pharmaceutical supply issues. ~Last week, we covered questions around potential #pharmaceutical #tariffs.
audacy.com/podcast/wwl-...
audacy.com/podcast/wwl-...
Honored to be on the Scientific Advisory Board of the #WorldVaccineCongress, which brings together top vaccine experts. Thanks to the panelists + engaged audience at this session on vaccine thermostability, from upstream tech to last-mile delivery. #vaccine #thermostability #supplychain
April 25, 2025 at 6:37 PM
Honored to be on the Scientific Advisory Board of the #WorldVaccineCongress, which brings together top vaccine experts. Thanks to the panelists + engaged audience at this session on vaccine thermostability, from upstream tech to last-mile delivery. #vaccine #thermostability #supplychain
Uncertainty in trade policy is undermining the imp. goal of pharma supply chain diversification and reducing geographic concentration. Policy unpredictability is stalling these critical decisions. Article by @hannahkuchler.bsky.social
& colleagues @financialtimes.com (link next)
@cfr.org
& colleagues @financialtimes.com (link next)
@cfr.org
April 15, 2025 at 12:54 AM
Uncertainty in trade policy is undermining the imp. goal of pharma supply chain diversification and reducing geographic concentration. Policy unpredictability is stalling these critical decisions. Article by @hannahkuchler.bsky.social
& colleagues @financialtimes.com (link next)
@cfr.org
& colleagues @financialtimes.com (link next)
@cfr.org
Since 2020, I have frequently joined Tommy Tucker and WWL Radio in New Orleans + the Gulf Coast on their morning show WWL First News to talk about pharmaceutical supply issues. This morning, we discussed questions surrounding potential pharmaceutical tariffs.
@cfr.org
audacy.com/podcast/wwl-...
@cfr.org
audacy.com/podcast/wwl-...
April 15, 2025 at 12:46 AM
Since 2020, I have frequently joined Tommy Tucker and WWL Radio in New Orleans + the Gulf Coast on their morning show WWL First News to talk about pharmaceutical supply issues. This morning, we discussed questions surrounding potential pharmaceutical tariffs.
@cfr.org
audacy.com/podcast/wwl-...
@cfr.org
audacy.com/podcast/wwl-...
Some pharma companies & distributors are stocking up the channel before the (potential) upcoming pharma tariffs take effect. The resulting "bullwhip effect" from this stockpiling will likely become more evident in the second half of 2025. @reuters.com @cfr.org
www.reuters.com/business/hea...
www.reuters.com/business/hea...
March 28, 2025 at 1:26 AM
Some pharma companies & distributors are stocking up the channel before the (potential) upcoming pharma tariffs take effect. The resulting "bullwhip effect" from this stockpiling will likely become more evident in the second half of 2025. @reuters.com @cfr.org
www.reuters.com/business/hea...
www.reuters.com/business/hea...
The policy debate about how to create incentives for expanded pharmaceutical manufacturing in the US doesn't get into what it means for "tax-optimized supply chains." @cfr.org colleague Brad_Setser delves into the effect of the 2017 Trump-Ryan tax reform on production location (link👇in next)
March 27, 2025 at 1:58 PM
The policy debate about how to create incentives for expanded pharmaceutical manufacturing in the US doesn't get into what it means for "tax-optimized supply chains." @cfr.org colleague Brad_Setser delves into the effect of the 2017 Trump-Ryan tax reform on production location (link👇in next)
Gepotidacin by @glaxosmithkline.bsky.social approved by the FDA for uncomplicated UTIs caused by some drug-resistant bacteria 👇. The development was funded partially with grants from HHS, ASPR, BARDA, and DTRA. Important data point about push vs. pull incentives for antibiotic development.
March 26, 2025 at 2:25 PM
Gepotidacin by @glaxosmithkline.bsky.social approved by the FDA for uncomplicated UTIs caused by some drug-resistant bacteria 👇. The development was funded partially with grants from HHS, ASPR, BARDA, and DTRA. Important data point about push vs. pull incentives for antibiotic development.
Meanwhile, major health systems like the US & EU struggle to systematically achieve the same level of upstream supply chain visibility.
Can they learn from the efforts of global health agencies?.
#upstream #supplychain #resilience learn from #globalhealth
(2/2)
Can they learn from the efforts of global health agencies?.
#upstream #supplychain #resilience learn from #globalhealth
(2/2)
March 7, 2025 at 12:12 AM
Meanwhile, major health systems like the US & EU struggle to systematically achieve the same level of upstream supply chain visibility.
Can they learn from the efforts of global health agencies?.
#upstream #supplychain #resilience learn from #globalhealth
(2/2)
Can they learn from the efforts of global health agencies?.
#upstream #supplychain #resilience learn from #globalhealth
(2/2)
Global health agencies (e.g., Global Fund, PEPFAR, USAID, UNITAID) have led the way in mapping upstream supply chains (KSM, API, FPP) & proactively addressing supply risks. 🌍📊 🏥🔍 #upstream #supplychain #visibility #globalhealth at #forefront (1/2)
www.thinkglobalhealth.org/article/mapp...
www.thinkglobalhealth.org/article/mapp...
March 7, 2025 at 12:12 AM
Global health agencies (e.g., Global Fund, PEPFAR, USAID, UNITAID) have led the way in mapping upstream supply chains (KSM, API, FPP) & proactively addressing supply risks. 🌍📊 🏥🔍 #upstream #supplychain #visibility #globalhealth at #forefront (1/2)
www.thinkglobalhealth.org/article/mapp...
www.thinkglobalhealth.org/article/mapp...
Irrespective of your views on US International Aid, please do read @jeremykonyndyk.bsky.social's essay in @nytimes.com today. He writes with firsthand experience of many of these programs and the genuine compassion of a true humanitarian.
www.nytimes.com/2025/02/21/o...
www.nytimes.com/2025/02/21/o...
February 21, 2025 at 4:38 PM
Irrespective of your views on US International Aid, please do read @jeremykonyndyk.bsky.social's essay in @nytimes.com today. He writes with firsthand experience of many of these programs and the genuine compassion of a true humanitarian.
www.nytimes.com/2025/02/21/o...
www.nytimes.com/2025/02/21/o...
Roche officially launches its SBX platform for NGS. An important tech for mainstreaming clinical use of NGS. Reminder of how transformative technologies trace their roots to early-stage NIH grants (in this case NHGRI grants to Stratos Genomics which Roche acquired).
www.roche.com/media/releas...
www.roche.com/media/releas...
February 21, 2025 at 3:51 PM
Roche officially launches its SBX platform for NGS. An important tech for mainstreaming clinical use of NGS. Reminder of how transformative technologies trace their roots to early-stage NIH grants (in this case NHGRI grants to Stratos Genomics which Roche acquired).
www.roche.com/media/releas...
www.roche.com/media/releas...
Understanding how pharmaceutical tariffs affect drug availability and pricing is important for all healthcare professionals. 👇 is a short breakdown of the issue in
@medpagetoday.bsky.social
@gfriedman.bsky.social
#pharma #tariffs #trade #SupplyChain
www.medpagetoday.com/opinion/seco...
@medpagetoday.bsky.social
@gfriedman.bsky.social
#pharma #tariffs #trade #SupplyChain
www.medpagetoday.com/opinion/seco...
February 20, 2025 at 9:40 PM
Understanding how pharmaceutical tariffs affect drug availability and pricing is important for all healthcare professionals. 👇 is a short breakdown of the issue in
@medpagetoday.bsky.social
@gfriedman.bsky.social
#pharma #tariffs #trade #SupplyChain
www.medpagetoday.com/opinion/seco...
@medpagetoday.bsky.social
@gfriedman.bsky.social
#pharma #tariffs #trade #SupplyChain
www.medpagetoday.com/opinion/seco...
👇my Valentine's Day message to colleagues working in international development, global health, and other social mission-oriented organizations.
February 14, 2025 at 2:57 PM
👇my Valentine's Day message to colleagues working in international development, global health, and other social mission-oriented organizations.